Low Research Lab
Dr. Philip S. Low joined the faculty at Purdue University in 1976, where he is currently the Ralph C. Corley Distinguished Professor of Chemistry.
Dr. Low has published over 270 refereed articles on various topics, including: 1) Structure and function of the human erythrocyte membrane, 2) Signal transduction across plant plasma membranes, 3) Design and development of receptor-targeted imaging and therapeutic agents for cancer and inflammatory diseases, and 4) Design and development of receptor-targeted imaging and therapeutic agents for cancer and inflammatory diseases.
Dr. Low currently serves on four editorial boards and several external advisory boards for major institutions. Dr. Low has received both of Purdue University's awards for outstanding research, an NIH Merit Award, and several national and international research awards. He has organized multiple international/national conferences and chaired two Gordon Conferences.
Dr. Low's research into receptor-targeted therapeutic and imaging agents has lead to more than 30 US patents/patents pending, and development of these patents has yielded 5 targeted drugs that are currently undergoing human clinical trials for kidney, ovarian, breast, lung, brain and endometrial cancers. Dr. Low has founded a company called Endocyte Inc. based on this latter technology.
(Click on photo to download high-quality image)